{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:09:55Z","timestamp":1775664595428,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bone marrow mesenchymal stem cells (BMSCs) can effectively alleviate liver fibrosis, which is a pathological injury caused by various chronic liver diseases. This study aimed to investigate the antifibrotic effects of BMSCs and elucidate the underlying mechanism by which BMSCs affect liver fibrosis in vitro and in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      After the rat liver fibrosis model was induced by continuous injection of carbon tetrachloride (CCl\n                      <jats:sub>4<\/jats:sub>\n                      ), BMSCs were administered for 4 weeks, and histopathological analysis and liver function tests were performed. T6 hepatic stellate cells (HSC-T6 cells) were stimulated by TGF-\u03b21, and the activation and proliferation of cells were analyzed by CCK-8 assays, flow cytometry, real-time PCR, western blotting and enzyme-linked immunosorbent assay (ELISA).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our data demonstrated that BMSCs effectively reduced the accumulation of collagen, enhanced liver functionality and ameliorated liver fibrosis in vivo. BMSCs increased the sub-G1 population in HSC-T6 cells. In addition, coculture with BMSCs reduced the expression of \u03b1-SMA, collagen I, cyclin-D1, and c-Myc in HSC-T6 cells and activated the phosphorylation of GSK3\u03b2. The GSK3\u03b2 inhibitor SB216763 reversed the effect of BMSCs. The Wnt\/\u03b2-catenin signalling pathway was involved in BMSC-mediated inhibition of HSC-T6 cell activation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data suggested that BMSCs exerted antifibrotic effects by activating the expression of GSK3\u03b2 and inhibiting the Wnt3a\/\u03b2-catenin signalling pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13027-022-00432-4","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T06:03:57Z","timestamp":1650348237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Rat bone marrow mesenchymal stem cells (BMSCs) inhibit liver fibrosis by activating GSK3\u03b2 and inhibiting the Wnt3a\/\u03b2-catenin pathway"],"prefix":"10.1186","volume":"17","author":[{"given":"Zhaoguo","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"432_CR1","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"S Friedman","year":"2003","unstructured":"Friedman S. Liver fibrosis\u2014from bench to bedside. J Hepatol. 2003;38:S38-53.","journal-title":"J Hepatol"},{"issue":"7","key":"432_CR2","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"T Wynn","year":"2012","unstructured":"Wynn T, Ramalingam T. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med. 2012;18(7):1028\u201340.","journal-title":"Nat Med"},{"key":"432_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.biopha.2017.08.011","volume":"95","author":"Z Hu","year":"2017","unstructured":"Hu Z, You P, Xiong S, Gao J, Tang Y, Ye X, Xia Y, Zhang D, Liu Y. Carapax Trionycis extracts inhibit fibrogenesis of activated hepatic stellate cells via TGF-\u03b21\/Smad and NF\u03baB signaling. Biomed Pharmacother. 2017;95:11\u20137.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"432_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/sctm.18-0105","volume":"8","author":"Y Watanabe","year":"2019","unstructured":"Watanabe Y, Tsuchiya A, Seino S, Kawata Y, Kojima Y, Ikarashi S, Starkey Lewis P, Lu W, Kikuta J, Kawai H, et al. Mesenchymal stem cells and induced bone marrow-derived macrophages synergistically improve liver fibrosis in mice. Stem Cells Transl Med. 2019;8(3):271\u201384.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"432_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.5966\/sctm.2015-0265","volume":"6","author":"L Chen","year":"2017","unstructured":"Chen L, Zhang C, Chen L, Wang X, Xiang B, Wu X, Guo Y, Mou X, Yuan L, Chen B, et al. Human menstrual blood-derived stem cells ameliorate liver fibrosis in mice by targeting hepatic stellate cells via paracrine mediators. Stem Cells Transl Med. 2017;6(1):272\u201384.","journal-title":"Stem Cells Transl Med"},{"issue":"2","key":"432_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3748\/wjg.v24.i2.237","volume":"24","author":"L Lan","year":"2018","unstructured":"Lan L, Liu R, Qin L, Cheng P, Liu B, Zhang B, Ding S, Li X. Transplantation of bone marrow-derived endothelial progenitor cells and hepatocyte stem cells from liver fibrosis rats ameliorates liver fibrosis. World J Gastroenterol. 2018;24(2):237\u201347.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"432_CR7","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jhep.2005.10.026","volume":"44","author":"S Oyagi","year":"2006","unstructured":"Oyagi S, Hirose M, Kojima M, Okuyama M, Kawase M, Nakamura T, Ohgushi H, Yagi K. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol. 2006;44(4):742\u20138.","journal-title":"J Hepatol"},{"key":"432_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12967-016-0792-1","volume":"14","author":"B Huang","year":"2016","unstructured":"Huang B, Cheng X, Wang H, Huang W, la Ga Hu Z, Wang D, Zhang K, Zhang H, Xue Z, Da Y, et al. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. J Transl Med. 2016;14:45.","journal-title":"J Transl Med"},{"issue":"1","key":"432_CR9","first-page":"81","volume":"16","author":"H El Baz","year":"2018","unstructured":"El Baz H, Demerdash Z, Kamel M, Atta S, Salah F, Hassan S, Hammam O, Khalil H, Meshaal S, Raafat I. Transplant of hepatocytes, undifferentiated mesenchymal stem cells, and in vitro hepatocyte-differentiated mesenchymal stem cells in a chronic liver failure experimental model: a comparative study. Exp Clin Transplant. 2018;16(1):81\u20139.","journal-title":"Exp Clin Transplant"},{"issue":"25","key":"432_CR10","doi-asserted-by":"publisher","first-page":"11737","DOI":"10.7150\/thno.47717","volume":"10","author":"H Zheng","year":"2020","unstructured":"Zheng H, Yang Z, Xin Z, Yang Y, Yu Y, Cui J, Liu H, Chen F. Glycogen synthase kinase-3\u03b2: a promising candidate in the fight against fibrosis. Theranostics. 2020;10(25):11737\u201353.","journal-title":"Theranostics"},{"issue":"1","key":"432_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12967-019-2027-8","volume":"17","author":"H Chen","year":"2019","unstructured":"Chen H, Gan Q, Yang C, Peng X, Qin J, Qiu S, Jiang Y, Tu S, He Y, Li S, et al. A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis. J Transl Med. 2019;17(1):280.","journal-title":"J Transl Med"},{"issue":"7","key":"432_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrneph.2016.54","volume":"12","author":"M Edeling","year":"2016","unstructured":"Edeling M, Ragi G, Huang S, Pavenst\u00e4dt H, Susztak K. Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog. Nat Rev Nephrol. 2016;12(7):426\u201339.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"432_CR13","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1053\/j.gastro.2015.02.056","volume":"148","author":"S Monga","year":"2015","unstructured":"Monga S. \u03b2-Catenin signaling and roles in liver homeostasis, injury, and tumorigenesis. Gastroenterology. 2015;148(7):1294\u2013310.","journal-title":"Gastroenterology"},{"issue":"1","key":"432_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.yexcr.2014.10.023","volume":"331","author":"C Wang","year":"2015","unstructured":"Wang C, Dai J, Sun Z, Shi C, Cao H, Chen X, Gu S, Li Z, Qian W, Han X. Targeted inhibition of disheveled PDZ domain via NSC668036 depresses fibrotic process. Exp Cell Res. 2015;331(1):115\u201322.","journal-title":"Exp Cell Res"},{"issue":"11","key":"432_CR15","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.ebiom.2015.10.010","volume":"2","author":"Y Osawa","year":"2015","unstructured":"Osawa Y, Oboki K, Imamura J, Kojika E, Hayashi Y, Hishima T, Saibara T, Shibasaki F, Kohara M, Kimura K. Inhibition of cyclic adenosine monophosphate (cAMP)-response element-binding protein (CREB)-binding protein (CBP)\/\u03b2-catenin reduces liver fibrosis in mice. EBioMedicine. 2015;2(11):1751\u20138.","journal-title":"EBioMedicine"},{"issue":"1","key":"432_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bbrc.2007.12.085","volume":"367","author":"C Kordes","year":"2008","unstructured":"Kordes C, Sawitza I, H\u00e4ussinger D. Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells. Biochem Biophys Res Commun. 2008;367(1):116\u201323.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"432_CR17","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/cbin.11068","volume":"42","author":"F Zhang","year":"2018","unstructured":"Zhang F, Wan X, Cao Y, Sun D, Cao C. Klotho gene-modified BMSCs showed elevated antifibrotic effects by inhibiting the Wnt\/\u03b2-catenin pathway in kidneys after acute injury. Cell Biol Int. 2018;42(12):1670\u20139.","journal-title":"Cell Biol Int"},{"issue":"1","key":"432_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s13287-018-1045-4","volume":"9","author":"E Zhang","year":"2018","unstructured":"Zhang E, Yang Y, Chen S, Peng C, Lavin M, Yeo A, Li C, Liu X, Guan Y, Du X, et al. Bone marrow mesenchymal stromal cells attenuate silica-induced pulmonary fibrosis potentially by attenuating Wnt\/\u03b2-catenin signaling in rats. Stem Cell Res Ther. 2018;9(1):311.","journal-title":"Stem Cell Res Ther"},{"issue":"9930","key":"432_CR19","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"E Tsochatzis","year":"2014","unstructured":"Tsochatzis E, Bosch J, Burroughs A. Liver cirrhosis. Lancet. 2014;383(9930):1749\u201361.","journal-title":"Lancet"},{"key":"432_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","volume":"68-69","author":"D Schuppan","year":"2018","unstructured":"Schuppan D, Ashfaq-Khan M, Yang A, Kim Y. Liver fibrosis: direct antifibrotic agents and targeted therapies. Matrix Biol. 2018;68\u201369:435\u201351.","journal-title":"Matrix Biol"},{"key":"432_CR21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jconrel.2021.03.016","volume":"332","author":"E Geervliet","year":"2021","unstructured":"Geervliet E, Moreno S, Baiamonte L, Booijink R, Boye S, Wang P, Voit B, Lederer A, Appelhans D, Bansal R. Matrix metalloproteinase-1 decorated polymersomes, a surface-active extracellular matrix therapeutic, potentiates collagen degradation and attenuates early liver fibrosis. J Control Release. 2021;332:594\u2013607.","journal-title":"J Control Release"},{"key":"432_CR22","doi-asserted-by":"publisher","first-page":"111160","DOI":"10.1016\/j.msec.2020.111160","volume":"116","author":"K Hussein","year":"2020","unstructured":"Hussein K, Park K, Yu L, Kwak H, Woo H. Decellularized hepatic extracellular matrix hydrogel attenuates hepatic stellate cell activation and liver fibrosis. Mater Sci Eng C Mater Biol Appl. 2020;116:111160.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"6","key":"432_CR23","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"S Friedman","year":"2008","unstructured":"Friedman S. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134(6):1655\u201369.","journal-title":"Gastroenterology"},{"key":"432_CR24","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1038\/ncomms3823","volume":"4","author":"I Mederacke","year":"2013","unstructured":"Mederacke I, Hsu C, Troeger J, Huebener P, Mu X, Dapito D, Pradere J, Schwabe R. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013;4:2823.","journal-title":"Nat Commun"},{"issue":"11","key":"432_CR25","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1038\/cti.2016.62","volume":"5","author":"K Brempelis","year":"2016","unstructured":"Brempelis K, Crispe I. Infiltrating monocytes in liver injury and repair. Clin Transl Immunol. 2016;5(11):e113.","journal-title":"Clin Transl Immunol"},{"issue":"7","key":"432_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman S. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017;14(7):397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"48","key":"432_CR27","doi-asserted-by":"publisher","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","volume":"22","author":"C Zhang","year":"2016","unstructured":"Zhang C, Yuan W, He P, Lei J, Wang C. Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol. 2016;22(48):10512\u201322.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"432_CR28","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki E, De Minicis S, Osterreicher C, Kluwe J, Osawa Y, Brenner D, Schwabe R. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med. 2007;13(11):1324\u201332.","journal-title":"Nat Med"},{"key":"432_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0014-5793(01)02656-4","volume":"502","author":"S Dooley","year":"2001","unstructured":"Dooley S, Delvoux B, Streckert M, Bonzel L, Stopa M, ten Dijke P, Gressner A. Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2\/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett. 2001;502:4\u201310.","journal-title":"FEBS Lett"},{"key":"432_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.molimm.2016.05.018","volume":"75","author":"D Zhou","year":"2016","unstructured":"Zhou D, Wang X, Wang Y, Xiang X, Liang Z, Zhou Y, Xu A, Bi C, Zhang L. MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt\/\u03b2-catenin pathway. Mol Immunol. 2016;75:151\u201360.","journal-title":"Mol Immunol"},{"issue":"4","key":"432_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.33549\/physiolres.932289","volume":"61","author":"Y Guo","year":"2012","unstructured":"Guo Y, Xiao L, Sun L, Liu F. Wnt\/beta-catenin signaling: a promising new target for fibrosis diseases. Physiol Res. 2012;61(4):337\u201346.","journal-title":"Physiol Res"},{"issue":"10","key":"432_CR32","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.3390\/ijms19103103","volume":"19","author":"K Nishikawa","year":"2018","unstructured":"Nishikawa K, Osawa Y, Kimura K. Wnt\/\u03b2-catenin signaling as a potential target for the treatment of liver cirrhosis using antifibrotic drugs. Int J Mol Sci. 2018;19(10):3103.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"432_CR33","doi-asserted-by":"publisher","first-page":"7405","DOI":"10.1111\/jcmm.15356","volume":"24","author":"Y Chen","year":"2020","unstructured":"Chen Y, Chen X, Ji Y, Zhu S, Bu F, Du X, Meng X, Huang C, Li J. PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt\/\u03b2-catenin signalling pathway. J Cell Mol Med. 2020;24(13):7405\u201316.","journal-title":"J Cell Mol Med"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-022-00432-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-022-00432-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-022-00432-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T05:12:55Z","timestamp":1650431575000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-022-00432-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["432"],"URL":"https:\/\/doi.org\/10.1186\/s13027-022-00432-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1390724\/v1","asserted-by":"object"}]},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,19]]},"assertion":[{"value":"24 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiment protocols were approved by the Animal Experiment Ethic Committee of Southern Medical University (Ethics No.: L2017062).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}